Tumor News and Research

RSS

Novel Translational Mechanism Selectively Drives Growth Proteins in Common Cancers

A previously unknown mechanism helps cancer cells selectively produce proteins that drive tumor growth - such as KRAS - in common cancers, according to new research from The University of Texas MD Anderson Cancer Center.

30 Oct 2026

“Izas, la princesa guisante” and Sant Joan de Déu Hospital Barcelona Launch an International Expert Tumor Board to Improve Care for Children with Gliomatosis Cerebri

The Spanish association “Izas, la princesa guisante” and the Pediatric Cancer Center Barcelona (PCCB) at Sant Joan de Déu Hospital have reached another milestone in the fight against childhood cancer: they have helped establish an international expert tumor board dedicated to pediatric gliomatosis cerebri.

28 Oct 2026

Researchers Develop Predictive Model for Mass Spectrometry Imaging

Andrei Fedorov and his team have found a way to take some of the guesswork out of mass spectrometry imaging (MSI), potentially giving scientists better tools to explore the molecules that influence our health.

27 Oct 2026

OGT Launches First Fusion MRD NGS Panel for AML to Expand Fusion Detection at MRD-Level Sensitivity

OGT, a leading global provider of genomic research and diagnostic solutions, today announced the launch of the SureSeq™ myPanel Myeloid Fusion MRD Panel, the first-to-market dedicated fusion MRD next-generation sequencing (NGS) panel for acute myeloid leukemia (AML).

27 Oct 2026

Long-Read Nanopore Sequencing Resolves Unexplained Tumor Mutations

Michigan's Oncology Sequencing Program, or MiOncoSeq, was the first of its kind in the nation to sequence patient tumors.

24 Oct 2026

Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01

Evaxion A/S, a clinical-stage TechBio company developing novel immunotherapies with its pioneering AI-Immunology™ platform, announces new three-year immune and clinical outcome data for personalized cancer vaccine EVX-01 in patients with advanced melanoma.

From Evaxion A/S 24 Oct 2026

Metabolic Reprogramming Enhances Gamma Delta CAR T Solid Tumor Clearance

By turning a patient's own immune cells into stronger cancer-fighting cells, CAR T-cell therapy has transformed how some blood cancers are treated. But it's been harder to extend this approach to solid tumors, including cancer that has spread to the bone.

21 Oct 2026

Dendritic Cell STING Activation Licenses Cytotoxic T Lymphocyte Priming

Immune checkpoint inhibitors (ICIs) have transformed cancer care, yet only a subset of patients benefit. A major barrier is tumor microenvironment (TME) heterogeneity: "hot" tumors are enriched with cytotoxic T lymphocytes (CTLs) and respond better, while "cold" tumors lack T-cell infiltration or are shielded by immunosuppressive barriers.

20 Oct 2026

Novel Molecular Pathway Identified to Combat T-Cell Exhaustion in Cancer

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center used a CRISPR screen to identify a key molecular pathway that drives exhaustion in cancer-fighting immune cells, limiting their ability to keep tumors under control.

16 Oct 2026

Immunometabolic Reprogramming Strategy Addresses Chronic Inflammatory Conditions

Colorectal cancer has become the leading cause of cancer-related death for people under 50. Its most common forms generally aren't treatable, either through conventional means like chemotherapy or newer immunotherapy drugs.

16 Oct 2026

INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro

INmune Bio Inc. and Quantum Computing Inc. today announced a collaboration to apply quantum computing, artificial intelligence (AI) and data analytics to identify new potential applications for XPro (XPro1595), INmune Bio's investigational treatment for Alzheimer's disease and other disease conditions.

From INmune Bio 15 Oct 2026

Comprehensive Analysis of Emerging Strategies for Targeting Cyclin-Dependent Kinases in Cancer

More than 30 years after the direct connection was established between the molecular machinery controlling cell division and cancer, a new paper traces the evolution of cyclin-dependent kinase research and outlines the next generation of CDK-targeted therapies.

15 Oct 2026

Lipid Nanoparticles Reprogram NK Cells Internally to Eliminate Cancerous T Cells

MIT engineers have developed a new way to program natural killer (NK) immune cells to target cancerous T cells or T cells that have become autoreactive, leading to diseases such as lymphoma and autoimmune hepatitis.

14 Oct 2026

New AI Model Decodes the Language of Immune Cell Movement

Researchers at The University of Texas MD Anderson Cancer Center and collaborating institutions in Texas developed an artificial intelligence (AI) model that helps explain how immune cells find their way to specific locations in the body and why they avoid others.

14 Oct 2026

Massive Tumor Cell Analysis Reveals Secret Mechanism Behind Pancreatic Cancer Resistance

A new analysis of nearly half a million cells from dozens of pancreatic tumors, led by researchers at UC San Diego Moores Cancer Center and New York University (NYU), reveals how pancreatic cancer cells continuously reshape their genetic makeup over time, enabling them to evade treatment.

14 Oct 2026

Single-Cell RNA Sequencing Maps Neuroblastoma Intratumoral Heterogeneity

Neuroblastoma is the most common solid tumor found outside of the brain in children, yet why some children respond well to treatment while others do not has remained poorly understood. St. Jude Children's Research Hospital scientists and their collaborators built one of the most comprehensive datasets of neuroblastoma cells to date, using it to define the tumor's cell types and identify a gene signature marking a malignant cell population tied to poor prognosis.

10 Oct 2026

Tumor News and Research

Novel Translational Mechanism Selectively Drives Growth Proteins in Common Cancers

“Izas, la princesa guisante” and Sant Joan de Déu Hospital Barcelona Launch an International Expert Tumor Board to Improve Care for Children with Gliomatosis Cerebri

Researchers Develop Predictive Model for Mass Spectrometry Imaging

OGT Launches First Fusion MRD NGS Panel for AML to Expand Fusion Detection at MRD-Level Sensitivity

Long-Read Nanopore Sequencing Resolves Unexplained Tumor Mutations

Evaxion Announces 89% Vaccine Target Precision and Sustained T-Cell and Clinical Responses at Three-Year Follow-Up in Phase 2 Trial with Personalized Cancer Vaccine EVX-01

Metabolic Reprogramming Enhances Gamma Delta CAR T Solid Tumor Clearance

Dendritic Cell STING Activation Licenses Cytotoxic T Lymphocyte Priming

Novel Molecular Pathway Identified to Combat T-Cell Exhaustion in Cancer

Immunometabolic Reprogramming Strategy Addresses Chronic Inflammatory Conditions

INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro

Comprehensive Analysis of Emerging Strategies for Targeting Cyclin-Dependent Kinases in Cancer

Lipid Nanoparticles Reprogram NK Cells Internally to Eliminate Cancerous T Cells

New AI Model Decodes the Language of Immune Cell Movement

Massive Tumor Cell Analysis Reveals Secret Mechanism Behind Pancreatic Cancer Resistance

Single-Cell RNA Sequencing Maps Neuroblastoma Intratumoral Heterogeneity

Retrotransposon Reactivation Suggests Reverse Transcriptase Inhibitors Lower Cancer Risk

Prime Editing Generates Genomic Ticker Tapes Tracing Millions of Developing Cells

Enzyme Knockdown Repolarizes Immune Cells for Targeted Immunotherapy

Mitochondrial Genome Dynamics Influence Intrinsic Tumor Aggressiveness

The Future of Vision Restoration With ReVision Implant

How a Single List Is Changing Visibility for Women in Science

How Avatar Medical's 3D Technology Is Transforming How We Visualize the Human Body

Editorial Focus eBook - Biopharmaceuticals (2nd edition)

Improving Cell Culture Efficiency with Image-Guided Automation

Improving Scalability in Organoid Research

Cosmetic Formulation and Manufacturing

Latest in Genomics